Pattanapanyasat K, Kotipun K, Yongvanitchit K, Hider R C, Kyle D E, Heppner D G, Walsh D S
Center of Excellence for Flow Cytometry, Office for Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Southeast Asian J Trop Med Public Health. 2001 Mar;32(1):64-9.
Using standard in vitro drug susceptibility methods, we assessed the antimalarial activity of 3 orally administered iron chelators (hydroxypyridinones) alone and in combination with conventional antimalarials drugs (quinine, mefloquine, artesunate, tetracycline, atovaquone) against a chloroquine-resistant Plasmodium falciparum isolate. When tested alone, all iron chelators and antimalarial compounds inhibited the growth of the parasites. IC50 values for iron chelators were 60-70 microM, whereas the IC50 values for antimalarial drugs were in nM ranges, with artesunate being the most potent. The derived isobolograms for the interaction of hydroxypyridinones and antimalarial drugs showed addition or mild antagonism, similar to desferroxamine (Sum of Fractional Inhibitory Concentration, sigma FIC < 0.5 or > 4.0). Despite the absence of synergy with conventional drugs, intrinsic antimalarial activity of hydroxypyridinones supports the continued assessment of these iron chelators as treatment adjuncts.
我们采用标准的体外药敏试验方法,评估了3种口服铁螯合剂(羟基吡啶酮)单独使用以及与传统抗疟药物(奎宁、甲氟喹、青蒿琥酯、四环素、阿托伐醌)联合使用时,对一株耐氯喹恶性疟原虫分离株的抗疟活性。单独测试时,所有铁螯合剂和抗疟化合物均能抑制疟原虫的生长。铁螯合剂的半数抑制浓度(IC50)值为60 - 70微摩尔,而抗疟药物的IC50值在纳摩尔范围内,其中青蒿琥酯的活性最强。羟基吡啶酮与抗疟药物相互作用的等效线图显示为相加或轻度拮抗作用,类似于去铁胺(分数抑制浓度总和,σFIC < 0.5或> 4.0)。尽管羟基吡啶酮与传统药物不存在协同作用,但其内在的抗疟活性支持继续评估这些铁螯合剂作为治疗辅助药物的可能性。